Homepage

Corporate Profile

Incorporated in California as well as in Europe and Asia, Regulon Inc. is a private biopharmaceutical company committed to the discovery and development of nano-pharmaceutics in oncology.

We Designed and produced the following anti-cancer Drugs:

  • LipoPlatin ™
  • LipoXal ™
  • LipoVil-12 ™

Regulon has developed a unique liposome encapsulation technology applicable to drugs, small molecules, peptides, proteins and viruses aiming at improving human lives and reducing the side effects of chemotherapy known to exacerbate the quality of life (QOL) of cancer patients.

LipoPlatin™

Lipoplatin, pictured on the left, is our best effort from 15 years of research & development, and we are constantly improving patient treatments by updating clinical procedures for a maximum efficacy in the fight against tumors.


Important drug & healthcare information can be obtained by visiting: The LipoPlatin™ Website.

Milestone results are available for your information below:

Monthly Newsletter

Subscribe to our newsletter to receive monthly updates, progress reports & news from the industry - Delivered to your inbox.

Enter your email address above & click submit


News & Press Realases

TitleDate
Lipoplatin™ can be administered to patients with renal insufficiency2012

Website Security Test
m.fuq
celebritaporno
escort